Should you buy UnitedHealth Group Incorporated stock now?
Yes, the technical signal for UnitedHealth Group Incorporated is currently BUY. UnitedHealth Group Incorporated trades at $404.15 as of 8/6/2026. The overall technical signal is: Buy. The technical analysis shows the following: MACD is positive (bullish trend) at 0.258 with falling momentum (signal: 3.078); RSI is at 46.8 (neutral zone); the stock is in a short-term downtrend (price below the 20-day average); the analyst price target of $475.23 points to 17.6% upside. This is a technical observation based on current data, not investment advice.
What is the price target for UnitedHealth Group Incorporated stock?
The average analyst price target for UnitedHealth Group Incorporated is $475.23. The current price is $404.15, which gives an upside of 17.6%. Based on this, the stock is considered undervalued. The fair value range (±10% of the price target) is between $427.71 and $522.75.
Is UnitedHealth Group Incorporated a dividend stock?
Yes, UnitedHealth Group Incorporated is a dividend stock with a dividend yield of 1.06%. The latest dividend was $2.32 per share. The latest ex-dividend date (traded without the dividend) was 6/15/2026. The payout ratio is 48.0%, which is considered sustainable. The next dividend payment is scheduled for 6/23/2026.
When does UnitedHealth Group Incorporated pay a dividend in 2026?
UnitedHealth Group Incorporated pays its next dividend on 6/23/2026. The latest dividend was $2.32 per share with an ex-dividend date of 6/15/2026. The dividend yield is 1.06%. The payout ratio of 48.0% points to a sustainable dividend with room to grow.
What is the risk of UnitedHealth Group Incorporated stock?
UnitedHealth Group Incorporated is rated as a stock with moderate risk. the annual standard deviation is 37.7%, which classifies the stock as moderate risk.
Is UnitedHealth Group Incorporated overvalued?
No, UnitedHealth Group Incorporated is considered undervalued based on the analyst price target (17.6% upside). UnitedHealth Group Incorporated has the following valuation ratios: a P/E ratio of 31.3 (highly valued), a P/S ratio of 0.8, a P/B ratio of 3.8. The analyst price target suggests that the stock is undervalued by 17.6%.
Is UnitedHealth Group Incorporated overbought?
No, UnitedHealth Group Incorporated is not overbought. RSI is at 46.8 (neutral zone). The technical indicators show: RSI is at 46.8 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 4.4% below the 20-day average (short-term downtrend). In addition, MACD is positive, but momentum is falling.
When is the next UnitedHealth Group Incorporated earnings report?
UnitedHealth Group Incorporated reports its next earnings on October 27, 2026. The stock currently trades at $404.15. With a P/E ratio of 31.3, the market will be watching closely whether earnings meet expectations.
Is UnitedHealth Group Incorporated shorted?
Yes, UnitedHealth Group Incorporated is shorted with 2.1% of the free float sold short. This is a moderate level of short selling, within the normal range for most stocks. Data is updated daily based on official filings with the SEC.
Are insiders buying UnitedHealth Group Incorporated stock?
No, insiders are not buying UnitedHealth Group Incorporated shares – they are net sellers. Over the last 3 months, insiders have made 0 purchases and 3 sales. On a net basis, 401,272 $ worth of shares were sold. Across the last 20 reported transactions, the split is 1 purchases and 19 sales, with a net 834,845 $ bought. Active sellers include Conway Patrick Hugh, Zaetta Christopher R, ROOS THOMAS E and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is UnitedHealth Group Incorporated a good stock?
Based on our total score, UnitedHealth Group Incorporated is rated as a good stock with a total score of 67 out of 100. The stock scores above average on value, quality and momentum – it is among the top 33% in our database. The score is made up of Value: 56/100, Quality: 66/100, Momentum: 80/100. In addition: analysts see 17.6% upside to the price target; a dividend of 1.06%; technical signal: Buy. Whether UnitedHealth Group Incorporated is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for UnitedHealth Group Incorporated stock?
The outlook for UnitedHealth Group Incorporated based on current data: the average analyst price target is $475.23 (+17.6%); the next earnings report is due on 10/27/2026, which can move the price; the P/E ratio is 31.3 (high – the market expects growth). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is UnitedHealth Group Incorporated stock falling?
UnitedHealth Group Incorporated is falling right now. The technical indicators show: the price is 4.4% below the 20-day average; insiders have mostly been selling the stock recently. For the latest context, see our technical analysis, insider section and news overview above.
How high can UnitedHealth Group Incorporated go?
The average analyst price target for UnitedHealth Group Incorporated is $475.23, which corresponds to a potential gain of 17.6% from the current price of $404.15. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can UnitedHealth Group Incorporated fall?
We lack enough history to give a specific floor for UnitedHealth Group Incorporated. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does UnitedHealth Group Incorporated do?
UnitedHealth Group, eller UNH, er et kæmpe sundhedsfirma, der tjener penge på flere fronter i USA. De driver fire store forretningsområder.
De sælger for eksempel sundhedsforsikringer og ydelser gennem deres UnitedHealthcare-del. Her tilbyder de planer til alt fra store arbej... The company belongs to the Sundhed sector, more specifically the Healthcare Plans industry, is headquartered in USA, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate UnitedHealth Group Incorporated as an investment.
Did UnitedHealth Group Incorporated raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from UnitedHealth Group Incorporated. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history and the news overview above.
Is UnitedHealth Group Incorporated making money or losing money?
Yes, UnitedHealth Group Incorporated is making money, not losing it. The company has a profit margin (the share of revenue left over as profit) of 3.1% — which is modest. The operating margin (profit before interest and taxes) is 7.1%. At a P/E ratio of 31.3, you currently pay 31.3 dollars for every dollar of the company's annual earnings. A consistently profitable company is usually more resilient than growth stocks that are not yet making money.
Can UnitedHealth Group Incorporated go bankrupt?
The bankruptcy risk of UnitedHealth Group Incorporated is rated as moderate. Altman Z2 (a model for assessing financial distress) is 1.22 — that places the company in the middle zone. The Piotroski score (financial health 0-9, higher is better) is 8 — which is strong. Debt relative to equity is 211% (high). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does UnitedHealth Group Incorporated have a lot of debt?
Yes, UnitedHealth Group Incorporated has elevated debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 211%. For the sundhed sector, anything above 150% counts as elevated — that raises the financial risk, especially if interest rates rise or earnings fall. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector. Can UnitedHealth Group Incorporated service its debt? Can service its debt without problems — the interest coverage ratio (how many times earnings can cover interest payments) is 8.2x, and net debt equals 1.7 years of earnings (EBITDA).
